FIELD: medicine.
SUBSTANCE: cardioplegic solution represents an aqueous solution containing potassium ions, magnesium ions with the pH of the solution from 7.1 to 8.9, which is provided by adding a pharmaceutically acceptable base and acid (versions).
EFFECT: cardioplegic solution is long-term storage-stable.
4 cl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CARDIOPLEGIA | 2016 |
|
RU2635523C2 |
| METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
| METHOD FOR CARDIOPLEGIC ARREST (VERSIONS) | 2015 |
|
RU2571058C1 |
| METHOD FOR COMBINED MYOCARDIAL PROTECTION AND A DEVICE FOR PERFORMING BLOOD COLD CARDIOPLEGIA IN HEART OPERATIONS IN NEWBORNS AND INFANTS | 2019 |
|
RU2706017C1 |
| NORMOTHERMIC CARDIOPLEGISTIC SOLUTION | 1997 |
|
RU2145843C1 |
| METHOD OF CARRYING OUT CARDIOPLEGIA | 2009 |
|
RU2434589C2 |
| METHOD FOR PROTECTING MYOCARDIUM IN REPERFUSION PERIOD | 2001 |
|
RU2209602C2 |
| METHOD OF ARTIFICIAL BLOOD CIRCULATION IN RECONSTRUCTIVE OPERATION ON AORTIC ARCH | 2019 |
|
RU2724871C1 |
| CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
| CARDIOPLEGIA AGENT (VERSIONS) | 2014 |
|
RU2568911C1 |
